(Q30384331)

21 June 2017

0 references

Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. (English)

1 reference

21 June 2017

Paul Robert Ingram

1

1 reference

21 June 2017

Tim Inglis

series ordinal

2

1 reference

21 June 2017

David Moxon

series ordinal

3

1 reference

21 June 2017

David Speers

series ordinal

4

1 reference

21 June 2017

publication date

1 March 2010

1 reference

21 June 2017

published in

Intensive Care Medicine

1 reference

21 June 2017

volume

36

1 reference

21 June 2017

issue

3

1 reference

21 June 2017

page(s)

528-532

1 reference

Procalcitonin in severe acute respiratory syndrome (SARS).

21 June 2017

cites work

1 reference

12 December 2020

Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets.

1 reference

12 December 2020

Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis.

1 reference

12 December 2020

Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit

1 reference

12 December 2020

Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index

1 reference

12 December 2020

Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin

1 reference

12 December 2020

Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections

1 reference

12 December 2020

Procalcitonin in children admitted to hospital with community acquired pneumonia

1 reference

12 December 2020

Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus

1 reference

12 December 2020

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

1 reference

12 December 2020

Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis

1 reference

12 December 2020

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.

1 reference

12 December 2020

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

1 reference

12 December 2020

Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators

1 reference

12 December 2020

Clinical characterisation of pneumonia caused by atypical pathogens combining classic and novel predictors

1 reference

12 December 2020

Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination?

1 reference

12 December 2020

10.1007/S00134-009-1746-3

Identifiers

DOI

1 reference

21 June 2017

0 references

1 reference